A Fujioka

747 total citations
16 papers, 680 citations indexed

About

A Fujioka is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, A Fujioka has authored 16 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Cancer Research and 4 papers in Molecular Biology. Recurrent topics in A Fujioka's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). A Fujioka is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Pancreatic and Hepatic Oncology Research (2 papers). A Fujioka collaborates with scholars based in Japan. A Fujioka's co-authors include Teiji Takechi, Junji Uchida, K Nakano, Setsuo Takeda, Hirofumi Satake, Tetsuhiko Shirasaka, Masakazu Fukushima, Norio Unemi, Hitoshi Saitô and Hiromi Okabe and has published in prestigious journals such as European Journal of Cancer, International Journal of Oncology and International Journal of Molecular Medicine.

In The Last Decade

A Fujioka

16 papers receiving 667 citations

Peers

A Fujioka

ONCOL

PRM

SURGE

Yuji Shimamoto Japan

Stefania Infusino Italy

Hirofumi Satake Japan

Kenji Mitsugi Japan

D. P. Ryan United States

K Nakano Japan

Lawrence P. Leichman United States

Moon Soo Lee South Korea

Mary Collier United States

Caio Max S. Rocha Lima United States

Yuji Shimamoto Japan

A Fujioka

584 ×1.2

ONCOL

413 ×1.2

PRM

346 ×2.0

160 ×1.2

SURGE

77 ×1.0

Citations per year, relative to A Fujioka A Fujioka (= 1×) peers Yuji Shimamoto

Countries citing papers authored by A Fujioka

Since Specialization

Citations

This map shows the geographic impact of A Fujioka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Fujioka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Fujioka more than expected).

Fields of papers citing papers by A Fujioka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Fujioka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Fujioka. The network helps show where A Fujioka may publish in the future.

Co-authorship network of co-authors of A Fujioka

This figure shows the co-authorship network connecting the top 25 collaborators of A Fujioka. A scholar is included among the top collaborators of A Fujioka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Fujioka. A Fujioka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Fujii, Shiro, et al.. (2024). A Nursing Pre-Transplant Intervention to Reduce Patients' Uncertainty about Allogeneic Hematopoietic Stem Cell Transplantation. PubMed. 6(4). 14–24. 1 indexed citations

Tanaka, Nobuyuki, A Fujioka, Keisuke Yamamura, et al.. (2012). 66 Trifluorothymidine Incorporation into DNA is the Primary Mechanism of Action of TAS-102, and Leads to Markedly Prolonged Survival in a Mouse Model. European Journal of Cancer. 48. 22–22. 1 indexed citations

Yokogawa, Tatsushi, Takeshi Wakasa, Kunihiro Yoshisue, et al.. (2012). 65 TAS-114 Enhances S-1 Activity in Vivo When Used in Combination. European Journal of Cancer. 48. 22–22. 5 indexed citations

Takechi, Teiji, A Fujioka, Eiji Matsushima, & Masakazu Fukushima. (2002). Enhancement of the antitumour activity of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase activity (DPD) using 5-chloro-2,4-dihydroxypyridine (CDHP) in human tumour cells. European Journal of Cancer. 38(9). 1271–1277. 78 indexed citations

Fukushima, Masakazu, A Fujioka, Junji Uchida, Fumio Nakagawa, & Teiji Takechi. (2001). Thymidylate synthase (TS) and ribonucleotide reductase (RNR) may be involved in acquired resistance to 5-fluorouracil (5-FU) in human cancer xenografts in vivo. European Journal of Cancer. 37(13). 1681–1687. 75 indexed citations

Uchida, Junji, Koji Sato, Hiroyuki Okabe, et al.. (2000). Experimental postoperative adjuvant chemotherapy by UFT using primary tumor amputation model.. International Journal of Molecular Medicine. 5(4). 357–62. 3 indexed citations

Fukushima, M, Hirofumi Satake, Junji Uchida, et al.. (1998). Preclinical antitumor efficacy of S-1: a new oral formulation of 5-fluorouracil on human tumor xenografts.. International Journal of Oncology. 13(4). 693–8. 95 indexed citations

Okabe, Hiroyuki, et al.. (1997). Augmentation of the chemotherapeutic effectiveness of UFT, a combination of tegafur [1-(2-tetrahydrofuryl)-5-fluorouracil] with uracil, by oral l-leucovorin.. PubMed. 17(1A). 157–64. 21 indexed citations

Takechi, Teiji, et al.. (1997). Enhancing 5-fluorouracil cytotoxicity by inhibiting dihydropyrimidine dehydrogenase activity with uracil in human tumor cells. International Journal of Oncology. 11(5). 1041–4. 32 indexed citations

10.

Kurebayashi, Junichi, Mamoru Nukatsuka, A Fujioka, et al.. (1997). Postsurgical oral administration of uracil and tegafur inhibits progression of micrometastasis of human breast cancer cells in nude mice.. PubMed. 3(5). 653–9. 25 indexed citations

11.

Yoshida, Masahiko, A Fujioka, K Nakano, et al.. (1996). Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.. PubMed. 16(3A). 1155–9. 1 indexed citations

12.

Yoshida, Masahiko, et al.. (1996). Activity of menogaril against various malignant lymphoma cell lines and a human lymphoma xenograft in mice.. PubMed. 16(5A). 2875–9. 2 indexed citations

13.

Shirasaka, Tetsuhiko, K Nakano, Hirofumi Satake, et al.. (1996). Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats.. PubMed. 56(11). 2602–6. 335 indexed citations

14.

Nukatsuka, Mamoru, et al.. (1996). [Prolongation of survival and antitumor activity of antitumor drugs in murine cancer cachexia model].. PubMed. 23(7). 887–92. 4 indexed citations

15.

Saito, Hirohisa, Hiroyuki Okabe, Kōichi Nakano, et al.. (1995). [Augmentation of chemotherapeutic efficaciousness of UFT by oral l-leucovorin--growth-inhibitory activity of combination against human tumor xenograft].. PubMed. 22(13). 1919–25. 1 indexed citations

16.

Nukatsuka, Mamoru, A Fujioka, Hitoshi Saitô, et al.. (1994). [Antitumor and anticachectic activity of UFT in BALB/c mice bearing colon 26 adenocarcinoma].. PubMed. 21(12). 2013–20. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact